-transparent.png){kind=logo}
We quantitated free kappa (kappa) and lambda light (L) chains in coded urine specimens from subjects with clinically definite multiple sclerosis (MS) (N = 56), other neurologic diseases (OND) (N = 30), and age-matched normal controls (N = 28). Urine from MS patients showed statistically significant increases in free L chains compared with the other groups, although there was overlap between MS patients and OND patients. The ratio of kappa/creatinine was significantly greater in the relapsing-remitting MS group than in patients with clinically stable MS, OND, and normal controls. Elevated free L chains were usually independent of urinary albumin and beta 2-microglobulin levels. Serial studies showed that urinary free kappa/creatinine ratios were elevated during periods of clinical worsening in seven of eight MS patients and subsequently decreased during clinical recovery. The measurement of free L chains in urine obtained at intervals from MS patients may be useful as a marker to monitor disease activity.
P D Mehta, and
S D Cook, and
R A Troiano, and
P K Coyle
January 1999,
Neurologia i neurochirurgia polska,
P D Mehta, and
S D Cook, and
R A Troiano, and
P K Coyle
June 1987,
Journal of neurology,
P D Mehta, and
S D Cook, and
R A Troiano, and
P K Coyle
October 1985,
Neurology,
P D Mehta, and
S D Cook, and
R A Troiano, and
P K Coyle
January 2017,
Annals of clinical biochemistry,
P D Mehta, and
S D Cook, and
R A Troiano, and
P K Coyle
July 1986,
Annals of neurology,
P D Mehta, and
S D Cook, and
R A Troiano, and
P K Coyle
March 2010,
Journal of neuroimmunology,
P D Mehta, and
S D Cook, and
R A Troiano, and
P K Coyle
August 1987,
Neurology,
P D Mehta, and
S D Cook, and
R A Troiano, and
P K Coyle
April 2019,
Expert review of molecular diagnostics,
P D Mehta, and
S D Cook, and
R A Troiano, and
P K Coyle
September 1998,
Acta neurologica Scandinavica,
P D Mehta, and
S D Cook, and
R A Troiano, and
P K Coyle
August 2021,
Clinical and experimental immunology,
